P04.17 – Newborn affected by maternal use of sedative-hypnotics
ICD-10-CM 2027 diagnosis code · Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery
- Code
P04.17(claims format:P0417)- Description
- Newborn affected by maternal use of sedative-hypnotics
- Billable
- Yes – valid for HIPAA-covered transactions
- Valid for
- Dates of service October 1, 2026 – September 30, 2027 (FY2027)
- Chapter
- 16. Certain conditions originating in the perinatal period (P00-P96)
- Block
- P00-P04 Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery
- Parent codes
- P04 › P04.1
Notes inherited from parent codes
Instructional notes at a category or block level apply to every code below it.
P04 – Newborn affected by noxious substances transmitted via placenta or breast milk
- nonteratogenic effects of substances transmitted via placenta
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
- any current condition in newborn, if applicable
P04.1 – Newborn affected by other maternal medication
Block P00-P04
- These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
Index terms for P04.17
Entries in the ICD-10-CM alphabetic index that lead to this code:
Related codes in P04.1
- P04.11 – Newborn affected by maternal antineoplastic chemotherapyBillable
- P04.12 – Newborn affected by maternal cytotoxic drugsBillable
- P04.13 – Newborn affected by maternal use of anticonvulsantsBillable
- P04.14 – Newborn affected by maternal use of opiatesBillable
- P04.15 – Newborn affected by maternal use of antidepressantsBillable
- P04.16 – Newborn affected by maternal use of amphetaminesBillable
- P04.1A – Newborn affected by maternal use of anxiolyticsBillable
- P04.18 – Newborn affected by other maternal medicationBillable
- P04.19 – Newborn affected by maternal use of unspecified medicationBillable
Frequently asked questions
What is ICD-10 code P04.17?
P04.17 is the ICD-10-CM code for newborn affected by maternal use of sedative-hypnotics, in the block P00-P04 (Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery).
Is P04.17 a billable code?
Yes. P04.17 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.
What category does P04.17 belong to?
It belongs to category P04 – Newborn affected by noxious substances transmitted via placenta or breast milk.
Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.